The invention relates to novel derivatives of hemin of general formula (I) and to the production and use thereof as antibacterial and/or antiviral agents, including in the formulation of pharmaceutical compositions. Advantages of the novel antibacterial and antiviral agents on the basis of derivatives of hemin include the biocompatibility and biodegradability thereof and the high degree of effectiveness thereof against resistant bacteria and widespread viruses which are dangerous to humans, and the lack of toxicity.